UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

From the medical to the social prescription: A fashion, a formal procedure, or are we going to think about it a little?

Semergen, medicina de familia, 2018-10, Vol.44 (7), p.447-448

2018

Volltextzugriff (PDF)

De la prescripción medicamentosa a la social: ¿una moda, un trámite protocolario o vamos a pensarlo un poco?

Semergen, medicina de familia, 2018-10, Vol.44 (7), p.447-448

2018

Volltextzugriff (PDF)

Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemia

Nature (London), 1993-09, Vol.365 (6441), p.65-69

1993

Volltextzugriff (PDF)

A 1.2V 56mW 10 bit 165Ms/s pipeline-ADC for HD-video applications

ESSCIRC 2008 - 34th European Solid-State Circuits Conference, 2008, p.270-273

2008

Volltextzugriff (PDF)

A 1.2 V 4.5 mW 10 bit 8 MS/s cyclic-ADC for mobile video and sensor applications

Elektrotechnik und Informationstechnik, 2009-11, Vol.126 (11), p.396-402

2009

Volltextzugriff (PDF)

A 40mW pseudo-differential 200MHz analog video pre-processing for HDTV flat-panel displays

2009 16th IEEE International Conference on Electronics, Circuits and Systems - (ICECS 2009), 2009, p.611-614

2009

Volltextzugriff (PDF)

Porcine pancreatic phospholipase A 2 isoforms: differential regulation by heparin

Biochimica et biophysica acta. Lipids and lipid metabolism, 1991, Vol.1082 (1), p.85-93

1991

Volltextzugriff (PDF)

236 (PB224): Tazemetostat and doxorubicin combined treatment in patient-derived preclinical models of epithelioid sarcoma

European journal of cancer (1990), 2024-10, Vol.211, p.114754, Article 114754

2024

Volltextzugriff (PDF)

Sorafenib inhibits lymphoma xenografts by targeting MAPK/ERK and AKT pathways in tumor and vascular cells

PloS one, 2013-04, Vol.8 (4), p.e61603-e61603

2013

Volltextzugriff (PDF)

Targeting COPZ1 in thyroid tumour cells

European journal of cancer (1990), 2016-07, Vol.61, p.S94-S94

2016

Volltextzugriff (PDF)

École, famille, cité : Pour une coéducation démocratique

2014

Volltextzugriff (PDF)

439 - Targeting COPZ1 in thyroid tumour cells

European journal of cancer (1990), 2016-07, Vol.61, p.S94-S94

2016

Volltextzugriff (PDF)

174 Quantification of 3D Tumor Vessel Networks by Vessel Caliber, Amount and Distribution, Allows Comparison Among Effects of Vascular-targeted Therapies

European journal of cancer (1990), 2012-07, Vol.48, p.S42-S42

2012

Volltextzugriff (PDF)

960 Combining Vascular Disruption Activity of TRAIL-expressing CD34+ Cells With Antiangiogenic Activity of Sorafenib Improves Regression of Tumor Growth

European journal of cancer (1990), 2012-07, Vol.48, p.S231-S231

2012

Volltextzugriff (PDF)

The histone Deacetylase Inhibitor Givinostat in Combination with Sorafenib Induces Reactive Oxygen Species (ROS) Generation and Exerts Potent Antitumor Effects in NOD/SCID Mice with Hodgkin Lymphoma Cell Line Xenografts

Blood, 2012-11, Vol.120 (21), p.3711-3711

2012

Volltextzugriff (PDF)

Induction of death receptor 5 expression in tumor vasculature by perifosine restores the vascular disruption activity of TRAIL-expressing CD34^sup +^ cells

Angiogenesis (London), 2013-09, Vol.16 (3), p.707

2013

Volltextzugriff (PDF)

Preclinical Rationale for the Use of the Combined Treatment with the AKT Inhibitor Perifosine and the Multikinase Inhibitor Sorafenib in Hodgkin Lymphoma

Blood, 2011-11, Vol.118 (21), p.1653-1653

2011

Volltextzugriff (PDF)

Abstract 640: The Akt inhibitor Perifosine strongly enhances the antitumor and antivascular activity of CD34+ cells engineered to express membrane-bound tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.640-640

2011

Volltextzugriff (PDF)

Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression

International journal of cancer, 1996-02, Vol.65 (4), p.491-497

1996

Volltextzugriff (PDF)

CD52 antigen expressed by malignant plasma cells can be targeted by alemtuzumab in vivo in NOD/SCID mice

Experimental hematology, 2006-06, Vol.34 (6), p.721-727

2006

Volltextzugriff (PDF)

Une histoire d’amour franco-britannique en Normandie

Études Normandes, 2017, Vol.3 (1), p.51-52

Cléris, Philippe

2017

Volltextzugriff (PDF)

Sorafenib Inhibits Lymphoma Xenografts by Targeting MAPK/ERK and AKT Pathways in Tumor and Vascular Cells. e61603

PloS one, 2013-04, Vol.8 (4)

2013

Volltextzugriff (PDF)

Preclinical Rationale for the Use of the Multikinase Inhibitor Sorafenib in the Treatment of Human Lymphomas

Blood, 2008-11, Vol.112 (11), p.2605-2605

2008

Volltextzugriff (PDF)

Human CD34+ Cells Expressing Membrane-Bound Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Exert a Potent Anti-Lymphoma Effects by Targeting Tumor Vasculature

Blood, 2007-11, Vol.110 (11), p.527-527

2007

Volltextzugriff (PDF)

Antitumor Activity of Human CD34+ Cells Expressing Membrane-Bound Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (mTRAIL)

Blood, 2006-11, Vol.108 (11), p.233-233

2006

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(32)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Animals
(6)
Humans
(6)
Antineoplastic Agents
(5)
Biological And Medical Sciences
(5)
Medical Sciences
(5)
Mice
(5)
Female
(4)
Pharmacology. Drug Treatments
(4)
Hematology, Oncology And Palliative Medicine
(3)
Male
(3)
Science & Technology
(3)
Adult
(2)
Antineoplastic Agents - Pharmacology
(2)
Crosstalk
(2)
Engineering
(2)
Engineering, Electrical & Electronic
(2)
Frequency
(2)
General Aspects
(2)
Medical Research
(2)
Mice, Inbred C57bl
(2)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

From the medical to the social prescription: A fashion, a formal procedure, or are we going to think about it a little?

De la prescripción medicamentosa a la social: ¿una moda, un trámite protocolario o vamos a pensarlo un poco?

Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemia

A 1.2V 56mW 10 bit 165Ms/s pipeline-ADC for HD-video applications

A 1.2 V 4.5 mW 10 bit 8 MS/s cyclic-ADC for mobile video and sensor applications

A 40mW pseudo-differential 200MHz analog video pre-processing for HDTV flat-panel displays

Porcine pancreatic phospholipase A 2 isoforms: differential regulation by heparin

236 (PB224): Tazemetostat and doxorubicin combined treatment in patient-derived preclinical models of epithelioid sarcoma

Sorafenib inhibits lymphoma xenografts by targeting MAPK/ERK and AKT pathways in tumor and vascular cells

Targeting COPZ1 in thyroid tumour cells

École, famille, cité : Pour une coéducation démocratique

439 - Targeting COPZ1 in thyroid tumour cells

174 Quantification of 3D Tumor Vessel Networks by Vessel Caliber, Amount and Distribution, Allows Comparison Among Effects of Vascular-targeted Therapies

960 Combining Vascular Disruption Activity of TRAIL-expressing CD34+ Cells With Antiangiogenic Activity of Sorafenib Improves Regression of Tumor Growth

The histone Deacetylase Inhibitor Givinostat in Combination with Sorafenib Induces Reactive Oxygen Species (ROS) Generation and Exerts Potent Antitumor Effects in NOD/SCID Mice with Hodgkin Lymphoma Cell Line Xenografts

Induction of death receptor 5 expression in tumor vasculature by perifosine restores the vascular disruption activity of TRAIL-expressing CD34^sup +^ cells

Preclinical Rationale for the Use of the Combined Treatment with the AKT Inhibitor Perifosine and the Multikinase Inhibitor Sorafenib in Hodgkin Lymphoma

Abstract 640: The Akt inhibitor Perifosine strongly enhances the antitumor and antivascular activity of CD34+ cells engineered to express membrane-bound tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)

Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression

CD52 antigen expressed by malignant plasma cells can be targeted by alemtuzumab in vivo in NOD/SCID mice

Une histoire d’amour franco-britannique en Normandie

Sorafenib Inhibits Lymphoma Xenografts by Targeting MAPK/ERK and AKT Pathways in Tumor and Vascular Cells. e61603

Preclinical Rationale for the Use of the Multikinase Inhibitor Sorafenib in the Treatment of Human Lymphomas

Human CD34+ Cells Expressing Membrane-Bound Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Exert a Potent Anti-Lymphoma Effects by Targeting Tumor Vasculature

Antitumor Activity of Human CD34+ Cells Expressing Membrane-Bound Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (mTRAIL)

Aktive Filter

Suchergebnisse filtern